Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) study

5 Feb 2017

Abstract excerpt

BACKGROUND: Red blood cell (RBC) antigen matching policies to prevent alloimmunization in females of childbearing potential (FCP) vary between centers. To inform transfusion centers responsible for making decisions about matching policies for FCPs, the causal stimulus of the antibodies implicated in severe hemolytic disease of the fetus and newborn (HDFN) must be determined. STUDY DESIGN AND METHODS: We conducted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood transfusion and management
Share to Blood groups and transfusion
Share to Neonatal Health and Biochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28164304
DOI: 10.1111/trf.13977

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Blood Group Antigen Matching Influence on Gestational Outcomes (AMIGO) studyPMID 28164304Read ↗

AFOG (African Federation of Obstetricians and Gynecologists) Comprehensive Guideline: Prevention and Management of Red Blood Cell Alloimmunization in PregnancySemantic proximity Read ↗

Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.Semantic proximity Read ↗

Retrospective analysis of HDFN due to ABO incompatibility in a single institution over 6 yearsSemantic proximity Read ↗

Prediction of fetal blood group and platelet antigens from maternal plasma using next-generation sequencing.Semantic proximity Read ↗

Cell-free DNA analysis for the determination of fetal red blood cell antigen genotype in alloimmunized pregnanciesSemantic proximity Read ↗

ACOG Clinical Practice Update: Paternal and Fetal Genotyping in the Management of Alloimmunization in PregnancySemantic proximity Read ↗

Assessment of human platelet antigen (HPA)-1a alloimmunisation in women identified at increased risk for foetal and neonatal alloimmune thrombocytopaenia (FNAIT): a prospective, natural history studySemantic proximity Read ↗

Genomewide association study of HLA alloimmunization in previously pregnant blood donors.Semantic proximity Read ↗

Is female sex a risk factor for red blood cell alloimmunization after transfusion? A systematic review.Semantic proximity Read ↗

Female alloimmunization with antibodies known to cause hemolytic diseaseSemantic proximity Read ↗

Sixty years of antibodies to MNS system hybrid glycophorins: what have we learned?Semantic proximity Read ↗

Intravenous Immunoglobulin (IVIG) as a Replacement for Anti-D Prophylaxis: A Systematic Review and Translational Analysis on the Future of Fetal Rhesus Alloimmunization PreventionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.